Tema Heart & Health ETF (HRTS)
NasdaqGM: HRTS
· 실시간 가격 · USD
37.27
+0.04 (0.11%)
종가 기준: Aug 17, 2026, 3:18 PM
Tema Heart & Health ETF (HRTS) ETF Price, Holdings & Analysis
0.11% (1D)
| 매수호가 | 26.28 |
| 시가총액 | n/a |
| 운용자산 | 54.27M |
| 순자산가치 | 37.19 |
| 베타 | n/a |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | 25.34 |
| 발행 주식수 | n/a |
| 설정일 | Nov 20, 2023 |
| 매도호가 | 47.47 |
| 거래량 | 4,486 |
| 평균 거래량 (20일) | 5,804 |
| 시가 | 37.06 |
| 전일 종가 | 37.23 |
| 당일 변동폭 | 37.06 - 37.36 |
| 52주 변동폭 | 29.02 - 37.82 |
| 편입 종목 | n/a |
| 총보수 | 0.75% |
HRTS 정보
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
상위 10종목 자산의 48.89%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Eli Lilly And Co | LLY | 11.32% |
| Unitedhealth Group I... | UNH | 5.50% |
| Novo Nordisk As Clas... | NOVO-B.CO | 5.12% |
| Thermo Fisher Scient... | TMO | 4.54% |
| Roche Holding Ag Adr | RHHBY | 4.18% |
| Merck & Co Inc | MRK | 4.16% |
| Johnson & Johnson | JNJ | 3.86% |
| Astrazeneca PLC | AZN.L | 3.46% |
| Revolution Medicines... | RVMD | 3.44% |
| Novartis Ag Register... | NOVN.SW | 3.31% |
